Profile
LFCR ZTS HLN TAK TEVA VTRS
Company Name Lifecore Biomedical, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $185.24M $88.09B $46.02B $44.63B $20.42B $14.11B
Employees 0.52K 14.10K 25.41K 49.28K 35.00K 33.00K
CEO Mr. Paul Josephs Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith
Ratings
LFCR ZTS HLN TAK TEVA VTRS
Quant Rating Score 2 3 3 3 1 2
Quant Rating Sell Neutral Neutral Neutral Strong Sell Sell
Trading
LFCR ZTS HLN TAK TEVA VTRS
Last Close $4.61 $194.44 $10.13 $14.08 $18.02 $11.82
High 52 $8.55 $200.09 $10.69 $15.08 $18.96 $13.53
Low 52 $3.82 $145.54 $7.78 $12.6 $8.12 $8.77
Price vs. 52 Week High -46.08 % -2.82 % -5.24 % -6.63 % -4.96 % -12.64 %
Price vs. 52 Week Low 20.68 % 33.6 % 30.21 % 11.75 % 121.92 % 34.78 %
Total Return
LFCR ZTS HLN TAK TEVA VTRS
1 Month Return -9.16 % -0.65 % -4.88 % -5.19 % 0.95 % 0 %
3 Month Return -16.64 % 6.81 % 13.57 % 2.77 % 10.01 % -0.17 %
6 Month Return -29.4 % 27.97 % 24.91 % 7.07 % 36.72 % 6.49 %
9 Month Return -30.15 % 1.85 % 19.46 % -5.22 % 63.37 % 3.14 %
YTD Return -25.53 % -1.48 % 23.09 % -1.33 % 72.61 % 9.14 %
1 Year Return -37.11 % 11.58 % 21.21 % -5.57 % 108.08 % 25.34 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LFCR ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 0.86 % 2.03 % 4.5 % - 4.06 %
Dividend Paid and Capex Coverage Ration (TTM) 0.44 % 2.01 % - 1.21 % 3.64 % 2.35 %
Dividend Per Share (TTM) - 1.67 % 0.16 % 0.63 % - 0.48 %
Payout Ratio (TTM) 12.33 % 31.57 % - 196.47 % - -89.13 %
Growth
LFCR ZTS HLN TAK TEVA VTRS
Asset Growth 7.27 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth 53.34 % 3.7 % 5.85 % -16.6 % 9.64 % 1.09 %
Revenue Growth 24.2 % 5.74 % 4.09 % 5.87 % 6.16 % -5.42 %
Revenue 3 Year -77.34 % 31.98 % 13.9 % 33.13 % -6.92 % -35.51 %
Revenue 5 Year -78.59 % 53.64 % 32.87 % 149.89 % -23.33 % -42.34 %
Revenue 10 Year -76.33 % 103.1 % 32.87 % 154.38 % -40.82 % -28.91 %
EBIT Growth 72.44 % 6.27 % 37.26 % 7.34 % -84.52 % 390.23 %
Net Income Growth 111.76 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 135.35 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 426.83 % 71.94 % 59.66 % 62.27 % 76.28 % -93.35 %
Net Income 10 Yeari Growth Per Share -44.79 % 404.24 % 59.66 % 36.33 % -133.42 % -97.2 %
Operating Income Growth 72.44 % 6.27 % 37.26 % 7.34 % -84.52 % 390.23 %
Operating Cash Flow Growth (CFG) 99.37 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG -101.39 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG -101.26 % 37.69 % 118.54 % 139.61 % -48.98 % -48.75 %
Operating 10 Year CFG -100.91 % 274.61 % 118.54 % 335.67 % -67.94 % -19.21 %
EPS Growth 111.44 % 12.64 % - -54.92 % 76.42 % -97.33 %
EPS Diluted Growth 109.68 % 12.92 % - -54.86 % 76.42 % -97.35 %
Book Value Per Share 2976.73 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share -74.45 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -81.43 % 139.55 % -39.41 % 73.27 % -53.44 % -27.89 %
Share Holder 10 Year Equity Growth Per Share -76.64 % 476.36 % -39.41 % 197.1 % -74.76 % 122.18 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth 15.63 % -15.91 % -9.43 % 24.67 % -6.53 % -4.64 %
Free Cash Flow Growth 67.15 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 26 May 2024 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
LFCR ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 34.65 % 68.75 % 59.91 % 62.49 % 49.52 % 41.24 %
Return on Assets TTM 2.65 % 16.55 % 3.26 % 0.92 % -1.15 % -1.43 %
Return on Equity TTM 17.23 % 46.65 % 6.54 % 2.08 % -6.77 % -3.2 %
Return on Capital Employed TTM -4.92 % 26.29 % 7.25 % 3.36 % 9 % -0.1 %
Net Income Per EBT TTM 113.08 % 81 % 65.38 % 292.06 % 287.88 % 101.02 %
EBT Per Ebit TTM -56.97 % 88.99 % 82.66 % 11.1 % -6.48 % 1649.48 %
EBIT Per Revenue TTM -7.9 % 36.48 % 17.88 % 10.48 % 15.62 % -0.25 %
Cash Flow To Debt Ratio TTM 5.84 % 39.73 % - 14.18 % 9.55 % 13.44 %
Receivables Turnover TTM 5.11 6.45 5.27 5.71 4.33 5.68
Payables Turnover TTM 4.66 6.63 1.25 3.53 3.48 4.57
Inventory Turnover TTM 2.02 1.14 3.09 1.3 2.1 2.27
Fixed Asset Turnover TTM 84.99 % 260.52 % 604.62 % 211.62 % 274.84 % 519.05 %
Asset Turnover TTM 52.04 % 62.94 % 33.71 % 27.2 % 39.43 % 33.62 %
Operating Cash Flow Per Share TTM 0.24 5.97 - 495.38 1.57 1.93
Free Cash Flow Per Share TTM -0.28 4.62 - 272.75 1.14 1.59
Cash Per Share TTM 17.89 % 345.55 % 5.72 % 54665.66 % 199.29 % 84.63 %
Operating Cash Flow Sales Ratio TTM 5.81 % 30.49 % - 17.61 % 10.92 % 15.07 %
Free Cash Flow Operating Cash Flow Ratio TTM -117.69 % 77.37 % - 55.06 % 72.53 % 82.48 %
Cash Flow Coverage Ratios TTM 5.84 % 39.73 % - 14.18 % 9.55 % 13.44 %
Price To Free Cash Flows Ratio TTM -21.07 41.89 - 15.6 15.81 7.45
Price To Operating Cash Flows Ratio TTM 20.78 32.59 - 4.25 11.47 6.13
Price Cash Flow Ratio TTM 20.78 32.59 - 4.25 11.47 6.13
Income Statement (TTM)
LFCR ZTS HLN TAK TEVA VTRS
Revenue $0.13B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $0.04B $5.83B $6.96B $2321.31B $7.65B $6.44B
Gross Profit Ratio 32.63% 68.28% 61.6% 54.44% 48.25% 41.74%
EBITDA $0B $3.56B $2.81B $1254.52B $4.27B $3.52B
Net Income $0.01B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted 0.33 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
LFCR ZTS HLN TAK TEVA VTRS
Long Term Debt $0.12B $6.56B $8.8B $4476.5B $18.48B $16.19B
Total Liabilities $0.22B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $0.05B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $-0B $0.02B $0.07B $683.22B $0.01B $0.36B
Total Debt $0.13B $6.8B $9.46B $5463.39B $20.15B $18.12B
Total Assets $0.27B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
LFCR ZTS HLN TAK TEVA VTRS
Net Income $0.01B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $0B $-0.36B $-0.13B $-115.74B $-0.15B $-0.61B
Dividends Paid $-0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $-0.02B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.49
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9511
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.415
ALVOW Alvotech 2.72
AMPH Amphastar Pharmaceuticals, Inc. 49.72
AMRX Amneal Pharmaceuticals, Inc. 8.465
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 60.1
AQST Aquestive Therapeutics, Inc. 4.92
ASRT Assertio Holdings, Inc. 1.16
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 13.92
AYTU Aytu BioPharma, Inc. 2.29
ETFs With Exposure to LFCR
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00944 226.13
VTI Vanguard Total Stock Market Index Fund 0 287.84
IWN iShares Russell 2000 Value ETF 0.01899 170.55
IWV iShares Russell 3000 ETF 0.00087 332.18
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02 42.37
HDG ProShares Hedge Replication ETF 0.000566182 49.991
UWM ProShares Ultra Russell2000 0.00115185 44.81
ONEQ Fidelity Nasdaq Composite Index ETF 0 72.395
IWC iShares Micro-Cap ETF 0.05566 128.3
URTY ProShares UltraPro Russell2000 0.000606296 55.46
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 70.73
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.08 40.65
RYLD Global X Russell 2000 Covered Call ETF 0.01 16.54
AVUS Avantis U.S. Equity ETF 0 97.06
DFAU Dimensional US Core Equity Market ETF 0 40.375
DFUS Dimensional U.S. Equity ETF 0 63.23
DFAT Dimensional U.S. Targeted Value ETF 0 56.76
DFAS Dimensional U.S. Small Cap ETF 0 66.32
DFAC Dimensional U.S. Core Equity 2 ETF 0 34.985
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0.01 19.0104
DFUV Dimensional US Marketwide Value ETF 0 42.685
DFSU Dimensional US Sustainability Core 1 ETF 0 37.94
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000260766 99.26
AVSC Avantis U.S. Small Cap Equity ETF 0.01 55.3837
RSSL Global X Funds 0 89.05
Unlock